Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.7150/thno.18069 http://scihub22266oqcxt.onion/10.7150/thno.18069 C5327647!5327647!28255364     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Theranostics 2017 ; 7 (3): 751-63 Nephropedia Template TP {{tp|p=28255364|t=2017. Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites |pdf=|usr=}}{{28255364}} gab.com Text Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites JO: Theranostics http://www.kidney.de/pget.php?&tw=1&pmid=28255364 #FOAvip Nanotechnology has become a powerful tool to potentially translate nanomedicine from bench to bedside. Nanotherapeutics are nanoparticles (NPs) loaded with drugs and possess the property of tissue targeting after surfaces of NPs are bio-functionalized. Designing smaller size of nanotherapeutics is presumed to increase tumor targeting based on the EPR (enhanced permeability and retention) effect. Since the immune systems possess a defence mechanism to fight diseases, there is an emerging concept that NPs selectively target immune cells to mediate the active delivery of drugs into sites of disease. In this review, we will focus on a key question of how nanotherapeutics specifically target immune cells and hijack them as a delivery vehicle to transport nanotherapeutics into disease tissues, thus possibly improving current therapies in inflammation, immune disorders and cancers. We will also discuss the challenges and opportunities for this new strategy of leukocyte-mediated delivery of nanotherapeutics. Twit Text FOAVip Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites ????Theranostics http://www.kidney.de/pget.php?&tw=1&pmid=28255364 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28255364 #FOAvip English Wikipedia <ref>{{Cite pmid|28255364}}</ref> Leukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tumor Sites #MMPMID28255364 Dong X; Chu D; Wang Z Theranostics 2017[]; 7 (3): 751-63 PMID28255364show ga Nanotechnology has become a powerful tool to potentially translate nanomedicine from bench to bedside. Nanotherapeutics are nanoparticles (NPs) loaded with drugs and possess the property of tissue targeting after surfaces of NPs are bio-functionalized. Designing smaller size of nanotherapeutics is presumed to increase tumor targeting based on the EPR (enhanced permeability and retention) effect. Since the immune systems possess a defence mechanism to fight diseases, there is an emerging concept that NPs selectively target immune cells to mediate the active delivery of drugs into sites of disease. In this review, we will focus on a key question of how nanotherapeutics specifically target immune cells and hijack them as a delivery vehicle to transport nanotherapeutics into disease tissues, thus possibly improving current therapies in inflammation, immune disorders and cancers. We will also discuss the challenges and opportunities for this new strategy of leukocyte-mediated delivery of nanotherapeutics. äLeukocyte-mediated Delivery of Nanotherapeutics in Inflammatory and Tu(epmc).pdf DeepDyve Pubget Overpricing